Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Harbor vs Rivo Health

Harbor
Graded #85

Higher grade

vs+0.29999999999999716
Rivo Health
Graded #89

Lower grade

The verdict

Harbor takes it — 72/100 to 71.7/100, but only just.

Harbor grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market. Rivo Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
74
74
Dose & formulationRivo Health +11
64
75
Clinical oversightHarbor +12
89
77
Labs & monitoringEven
63
63
FulfillmentRivo Health +3
81
84
Contract termsHarbor +6
47
41
Harbor · left barRivo Health · right bar

The numbers

MetricHarborRivo Health
WeighScore72/10071.7/100
GradeCC
Scorecard rank#85#89
Semaglutide$99/mo (starting dose, compounded)$149/mo (compounded)
Tirzepatide$149/mo (starting dose, compounded)$199/mo (compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Harbor

Graded #85 · C

Strengths

  • Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
  • LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
  • 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
  • 12-Month Money Back Guarantee if you don't reach your weight-loss goal
  • HSA/FSA eligible; no hidden fees, no insurance billed

Where it loses points

  • Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
  • Dietitian support offered only post-program (maintenance phase), not during active treatment
  • State-specific consultation types vary; nationwide availability unconfirmed for all states
  • No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
  • Newer brand; success rate and member counts are on-site claims, not third-party verified
Rivo Health

Graded #89 · C

Strengths

  • Compounded semaglutide and tirzepatide as both injections and oral options, starting around $149/mo (sema) and $199/mo (tirz)
  • Bundles dietitians, live workouts, support groups and mental-health coaching with the medication, not just a prescription
  • Insurance concierge to maximize coverage, FSA/HSA eligible, with multi-month plans that cut the price further
  • Large, established program (115,000+ members, Trustpilot 4.7) available nationwide

Where it loses points

  • Uses partner compounding pharmacies it doesn't name on the site
  • Headline prices are Spring-sale rates — everyday cost is higher and the deepest discounts need a 6-month commitment
  • Weight loss is one of several verticals (ED, longevity, sleep, hair, skin), not a single focus
  • Some bundled perks (e.g. meal prep) are paid add-ons rather than included

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard